Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inogen Inc Director's Dealing 2018

Feb 21, 2018

33625_dirs_2018-02-20_35da4899-7e7d-4c26-a619-b96bde2aa2be.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2018-02-16

Reporting Person: Bauerlein Alison (EVP, Finance, & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-02-16 Common Stock M 8808 $38.54 Acquired 8808 Direct
2018-02-16 Common Stock S 8808 $125.0308 Disposed 0 Direct
2018-02-20 Common Stock M 3192 $38.54 Acquired 3192 Direct
2018-02-20 Common Stock S 2992 $125.3527 Disposed 200 Direct
2018-02-20 Common Stock S 200 $126.26 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-02-16 Stock Option (Right to Buy) $38.54 M 8808 Disposed 2022-05-15 Common Stock (8808) Direct
2018-02-20 Stock Option (Right to Buy) $38.54 M 3192 Disposed 2022-05-15 Common Stock (3192) Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017.

F2: Represents the weighted average share price of an aggregate total of 8,808 shares sold in the price range of $125.00 to $125.30 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Represents the weighted average share price of an aggregate total of 2,992 shares sold in the price range of $125.00 to $125.97 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015.